Tag Archives: Into

Pfizer Japan drawn into valsartan recall after finding API from Mylan is tainted

The global recall of valsartan has now extended to Pfizer and to Japan, via Mylan and India. According to a translated copy of its announcement, Pfizer’s Tokyo-based Japanese subsidiary said it is recalling from the country five lots of its blood pressure combo drug Amubaro because its API contains impurities that are probable carcinogens. The recall began… Read More »

NIST releases Risk Management Framework 2.0 to combine privacy, security and supply chain into one

The National Institute of Standards and Technology posted the newest update to its Risk Management Framework. “RMF 2.0 is the first framework in the world to address security, privacy, and supply chain risk in an integrated manner — at the organization, mission/business process, and system levels,” NIST Fellow Ron Ross wrote in a Twitter post.… Read More »